AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Actinium Pharmaceuticals, Inc.
$1.48
+$0.11 (+8.03%)
Previous Close
$1.53
Day Range
$1.45$1.53
Year Range
$0.73$1.72
Market Cap
46.53M
AVG Volume
163.12K
Trailing/Forward PE
4.11/-
PEG ratio
-0.04
Dividend Yield
-
Next Earnings Date
2026-11-13
Primary Exchange
New York Stock Exchange Arca
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: ATNM
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 13 Nov 2026.
Video analysis: ATNM
All videosNo video analysis for this stock yet. Request one from our team.
News: ATNM
Similar companies
-
PDS Biotechnology Corporation
PDSB
·
NASDAQ
Compare
-
Xilio Therapeutics, Inc.
XLO
·
NASDAQ
Compare
-
Tempest Therapeutics, Inc.
TPST
·
NASDAQ
Compare
-
OnKure Therapeutics, Inc.
OKUR
·
NASDAQ
Compare
-
Reviva Pharmaceuticals Holdings, Inc.
RVPH
·
Other OTC
Compare
-
Tvardi Therapeutics, Inc.
TVRD
·
NASDAQ
Compare